Irrespective of the ultimate treatment rendered, lifestyle and risk factor modification is critical to the long-term success in the management of Peripheral Artery Disease (“PAD”). While one of the more important risk factors leading to PAD, genetics, cannot be modified, those that can be altered must be addressed if PAD is to be treated successfully.
Disease of the carotid artery is related to, in large part, the amount of atherosclerosis (or plaque) that is present in one of the main arteries to the brain—the Internal Carotid Artery (“ICA”). Typically, the more plaque that is present, the narrower the diameter of the internal portion of the artery is that is delivering blood to the brain.
While not truly a “treatment” for abdominal aortic aneurysms (“AAA”), most of the patients seen at The Cardiovascular Care Group with this condition are managed by simply watching the AAA! Most AAAs do not need to be operated upon and, therefore, simply monitoring them on a regular basis is the best “therapy!”
Hemodialysis, at its most basic, allows a machine to replace the function of the kidneys in patients whose kidney function has deteriorated.
The treatment options for vein conditions vary with the disease being treated. Vein disease can range from unsightly spider veins (“telangiectasias”) to life-threatening blood clots the obstruct blood flowing out of the veins of the leg or into the lung. It can also be the cause of leg swelling or discomfort that many people experience on a daily basis.
The Cardiovascular Care Group with convenient office locations has partnered with the Heart Health Foundation to offer the Dare to C.A.R.E. screening program.